Table 2 Clinical manifestations of the studied patients
Total (n = 103) | SLE without APS (n = 75) | SLE + APS (n = 28) | P-value | |
|---|---|---|---|---|
Musculoskeletal manifestations | 71 (68.9) | 51 (68.0) | 20 (71.4) | 0.738 |
Mucocutaneous manifestations | 66 (64.1) | 49 (65.3) | 17 (60.7) | 0.664 |
Serositis | 5 (4.9) | 3 (4.0) | 2 (7.1) | 0.611 |
Renal manifestations | 62 (60.2) | 45 (60.0) | 17 (60.7) | 0.947 |
Hematological manifestations | 57 (55.3) | 41 (54.7) | 16 (57.1) | 0.822 |
Cardiac manifestations | 10 (9.7) | 6 (8.0) | 4 (14.3) | 0.338 |
Vascular manifestations | 16 (15.5) | 5 (6.7) | 11 (39.3) | < 0.001** |
Neurological manifestations | 24 (23.3) | 11 (14.7) | 13 (46.4) | < 0.001** |
Psychiatric manifestations | 10 (9.7) | 7 (9.3) | 3 (10.7) | 0.833 |
Pulmonary manifestations | 14 (13.6) | 8 (10.7) | 6 (21.4) | 0.156 |
Abortion | 12 (11.7) | 4 (5.3) | 8 (28.6) | < 0.001** |